Drugmakers again call on Russian government to ease registration procedure

Both Russian and global pharmaceutical producers operating in the local market have called on the national government to ease the process of registration of drugs in Russia, reports The Pharma Letter’s local correspondent.

According to producers, it is still unprofitable to register new drugs in Russia under the current system of state regulation, with one of the major reasons for this being a state monopoly on the production and distribution of a number of drugs.

In addition, producers say there are at least three restrictive lists of drugs in Russia. The first is comprised of drugs the sale of which is generally prohibited in the Russian market. The second is strong painkillers and addiction-potential drugs, such as morphine. In the case of morphine and similar drugs, due to their specifics, only certain enterprises in Russia have the right to use and distribute them. One of such enterprises is the FSUE ‘Moscow Endocrine Plant’.